Pennsylvania's Medicaid program is a lifeline for vulnerable populations, including children, people with disabilities, older adults, and people who are battling substance use disorder. When Governor Tom Wolf expanded Medicaid in 2015, even more Pennsylvanians were able to get covered and get connected to critical health care services.
Medicaid provides health coverage to millions of Americans, including children, pregnant women, parents, seniors and individuals with disabilities. In some states the program covers all low-income adults below a certain income level.
When Governor Tom Wolf expanded Medicaid in 2015, more Pennsylvanians than ever were able to access quality health care coverage. The expansion opened up Medicaid to even more people living on low incomes, people who had been diagnosed with substance use disorder, and others.
The Department of Human Services is focused on improving access to health care in Pennsylvania while reducing Medicaid spending. DHS has begun to reward health care providers for the quality of their care, focus on preventive screenings, and work to limit costly and sometimes unnecessary services, such as an overuse of emergency rooms.
The county aggregate number of individuals on Medical Assistance (MA, Medicaid) who have filled a Naloxone Prescription. This includes all individuals on Medicaid. Naloxone is an opioid antagonist. It acts on the CNS to block the effects of narcotics, especially the "high'' feeling that makes you want to use them. It will not produce any narcotic-like effects or cause mental or physical dependence. Numbers are for the Calendar Year and updated with as current as possible until the next data refresh.
Every year, CMS will update the Open Payments data at least once after its initial publication. The refreshed data will include updates to data disputes and other data corrections made since the initial publication of this data documenting payments or transfers of value to physicians and teaching hospitals, and physician ownership and investment interests. This financial data is submitted by applicable manufacturers and applicable group purchasing organizations (GPOs).
This dataset summarizes the number of live births in 2016 or 2017 and indicates how many of those neonates or newborns on Medical Assistance (MA) were diagnosed in their first 90 days of life with Neonatal Abstinence Syndrome (NAS) (withdrawal symptoms or otherwise affected from maternal use of drugs of addiction).
The home of Medicaid and CHIP open data provided by the Federal Government.
Conduct research and design data visualizations using open data from Medicaid and the Children's' Health Insurance Program (CHIP)